The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 9 Mar 2004
doi: 10.1242/jcs.01018
Research Article
Role of tau phosphorylation by glycogen synthase kinase-3
in the regulation of organelle transport
Yoshitaka Tatebayashi,
Niloufar Haque,
Yunn-Chyn Tung,
Khalid Iqbal,
and
Inge Grundke-Iqbal*
* Author for correspondence (e-mail: i g iqbal{at}yahoo.com)
Anterograde organelle transport is known to be inhibited by overexpression of the microtubule-associated protein tau in cultured cells. However, the molecular mechanism regulating this function of tau protein has not previously been understood. We found that in PC12 cells treated with NGF or fibroblast growth factor-2, glycogen synthase kinase-3
and tau were upregulated simultaneously from around day 2 of differentiation, with increasing glycogen synthase kinase-3-mediated tau phosphorylation. This phosphorylation did not alter tau's ability to bind to microtubules but appeared to be required for the maintenance of the anterograde organelle transport in differentiated cells. Lithium, alsterpaullone or valproate, three independent glycogen synthase kinase-3 inhibitors, but not butyrolactone 1, an inhibitor of cyclin-dependent protein kinases, induced mitochondrial clustering in association with tau dephosphorylation. In CHO cells transfected with human tau441, mitochondrial clustering was found in cells in which tau was unphosphorylated. These findings raise the possibility that the phosphorylation of tau by glycogen synthase kinase-3 might be involved in the regulation of organelle transport.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Acevedo, J. Ding, and G. D Smith
Insulin Signaling in Mouse Oocytes
Biol Reprod,
November 1, 2007;
77(5):
872 - 879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Escobar-Khondiker, M. Hollerhage, M.-P. Muriel, P. Champy, A. Bach, C. Depienne, G. Respondek, E. S. Yamada, A. Lannuzel, T. Yagi, et al.
Annonacin, a Natural Mitochondrial Complex I Inhibitor, Causes Tau Pathology in Cultured Neurons
J. Neurosci.,
July 18, 2007;
27(29):
7827 - 7837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Swain, J. Ding, D. L. Brautigan, E. Villa-Moruzzi, and G. D. Smith
Proper Chromatin Condensation and Maintenance of Histone H3 Phosphorylation During Mouse Oocyte Meiosis Requires Protein Phosphatase Activity
Biol Reprod,
April 1, 2007;
76(4):
628 - 638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Kim, Y. Shi, R. C. Austin, and G. H. Werstuck
Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3
J. Cell Sci.,
January 1, 2005;
118(1):
89 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. V. W. Johnson and W. H. Stoothoff
Tau phosphorylation in neuronal cell function and dysfunction
J. Cell Sci.,
November 15, 2004;
117(24):
5721 - 5729.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2004